Posts about GBI comparing them with Diagene and Third Wave Technologies are a bit away with the fairies. Third wave has FDA approved technology (cystic fibrosis test) and has recently filed a full FDA submission for its 14 type high risk HPV test and its type 16/18 genotyping test after successful clinical trails, that’s why they are worth a lot of money. Diagene are FDA approved and are currently the only game in town in the U.S market, that’s why they are worth a lot of money. Diagene will only have the U.S market to themselves, until Roche finally gets FDA approval for its automated amplicor HPV and linear array tests for which it already has a CE licence, and there worth lot’s of money anyway. GBI has an “in house” investigational use licence with Sonic and are years away if ever from full FDA approval, that’s why there worth F…… not a lot.
To be fair GBI have done a good job on a shoestring but I think its technology is a bit outdated and has too little too late.
Note to Deca: Genera uses an old hybridisation technique not solid phase PCR.
GBI Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
